Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Hypertension
Interventions
DRUG

Candesartan cilexetil and hydrochlorothiazide

Candesartan cilexetil 16 mg, tablets, orally, once daily for 1 week; increased to candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg combination tablet, orally once daily for 2 weeks; then increased to candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg combination tablets, orally, once daily for up to 6 weeks

Trial Locations (16)

Unknown

Berlin

Blankenhain

Dortmund

Hamburg

Köthen

Löhne

Nuremberg

Remscheid

Rodgau

Stockach

Wardenburg

Weinheim

Ivano-Frankivsk

Kharkiv

Kiev

Lviv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY